The dose escalation phase (weeks 416, depending on the specific medication) involves gradually increasing the dose according to the prescribed schedule
slows digestion, and enhances insulin secretionkey mechanisms for blood sugar and weight regulation
These medications are sometimes covered when prescribed for diabetes management, but coverage for weight loss alone may be more limited
Severe gastrointestinal conditions: Those with delayed gastric emptying, gastroparesis, or chronic GI dysmotility may experience exacerbated symptoms due to the drugs action on gastric motility
Unsupervised telehealth prescribing of semaglutide without metabolic evaluation, without addressing the hormonal contributors to weight gain, and without structured dose titration produces variable results and misses the clinical opportunity
"The biggest con is really the price